Opposition and Activists Target Government Over Maternal Deaths
Rajasthan's maternal health crisis has come under sharp scrutiny as opposition parties and health activists have put the state government on the defensive. Rising maternal mortality rates and reports of inadequate healthcare facilities have triggered a political firestorm, with demands for urgent action and accountability.
WHO Seeks Report on Spurious Oxytocin
In a related development, the World Health Organisation (WHO) has formally requested the Indian government to submit a pharmacovigilance report on the potential spread of spurious oxytocin across the country. Oxytocin is a critical drug used to prevent postpartum hemorrhage, a leading cause of maternal deaths. The WHO has expressed concern that counterfeit versions of the drug could pose a serious danger to public health, particularly in states like Rajasthan where maternal mortality remains high.
Government's Response Under Fire
The state government has faced intense questioning from the opposition over its handling of maternal health schemes. Activists have pointed to gaps in the supply chain of essential medicines, lack of trained staff in rural health centers, and poor implementation of programs like Janani Suraksha Yojana. According to recent data, Rajasthan's maternal mortality ratio (MMR) remains above the national average, with 195 deaths per 100,000 live births, compared to the national average of 113.
Impact on Public Health
The crisis has highlighted systemic failures in Rajasthan's healthcare system. Experts warn that without immediate intervention, the state may fail to meet the Sustainable Development Goal (SDG) target of reducing MMR to 70 per 100,000 live births by 2030. The WHO's involvement underscores the gravity of the situation, as spurious oxytocin could exacerbate risks for pregnant women. Activists have called for a comprehensive audit of drug quality and distribution networks.
Political Implications
The issue has become a major political flashpoint ahead of upcoming state elections. The opposition has accused the ruling party of negligence, while the government has defended its record, citing increased funding for maternal health programs. However, critics argue that funds have not translated into improved outcomes on the ground. The WHO's request for a pharmacovigilance report adds international pressure on both state and central governments to address the crisis.
